Leveraging protein quaternary structure to identify oncogenic driver mutations

Gregory A Ryslik1, Yuwei Cheng2, Yorgo Modis3

  • 1Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA. gregory.ryslik@yale.edu.

BMC Bioinformatics
|March 23, 2016
PubMed
Abstract

Insights

Identifying cancer driver mutations is crucial for oncology drug development. Our new QuartPAC method effectively detects mutation clusters in protein structures, improving cancer research.

Area of Science:

  • Computational Biology
  • Genomics
  • Structural Biology

Background:

  • Identifying cancer-causing "driver" mutations is essential for targeted oncology drug development.
  • Distinguishing driver mutations from benign "passenger" mutations is a significant challenge in cancer research.
  • Driver mutations are hypothesized to cluster in specific protein regions, driving research into clustering algorithms.

Purpose of the Study:

  • To develop a novel computational methodology for identifying non-random mutational clustering in proteins.
  • To leverage protein quaternary structure in three-dimensional space for mutation analysis.
  • To improve the detection of functionally significant mutation clusters in cancer.

Main Methods:

  • Developed QuartPAC (Quaternary Protein Amino acid Clustering), a novel methodology.
  • Integrated spatial data from the Protein Data Bank (PDB).
  • Incorporated mutational data from the Catalogue of Somatic Mutations in Cancer (COSMIC).

Main Results:

  • QuartPAC identifies non-random mutational clusters using protein quaternary structure.
  • The method detects clusters missed by existing approaches.
  • Demonstrated utility across various proteins by integrating PDB and COSMIC data.

Conclusions:

  • QuartPAC offers a unique computational tool for identifying mutational clustering.
  • The methodology accounts for complete protein quaternary structure in its analysis.
  • Provides a valuable approach for cancer driver mutation research.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

6.0K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.4K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

3.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.9K